MeSH D011085 - polycystic ovary syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals | Urofollitropin | Bravelle | 2002-05-06 |
Clinical Trials
Historical Success Rate
Phase 1
70%28/40
Phase 2
61%23/38
Phase 3
75%27/36
Approved: 1Overall Success rate: 32%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use